Docetaxel in hormone-sensitive prostate cancer with low Gleason scores: A meta-analysis of randomized controlled trials.


Dizdar O., Guven D. C., Guner G., Erman M., Hayran M.

JOURNAL OF CLINICAL ONCOLOGY, vol.36, no.15, 2018 (SCI-Expanded, Scopus) identifier